Email Forum    |    Search

Ask Dr. Stephan Moll

These questions have been submitted by folks on the mailing list and answered by Dr. Moll, Director of the Thrombophilia Program at the Carolina Cardiovascular Biology Center, Department of Medicine, Division of Hematology-Oncology, UNC Chapel Hill (North Carolina, USA). Why am I doing this?

Print Question

58. Low platelets and clotting

Last Updated: 2/15/2004


Q: "I was diagnosed with Factor V Leiden last year after developing a blood clot in my leg. Yesterday my 17-year-old daughter was diagnosed with a blood clot in her leg. The strange part is that 3 years ago she was diagnosed with chronic ITP [Idiopathic Thrombocytopenia Purpura], and has been treated with steroids ever since. Doesn't this seem conflicting?? At present, her platelet count is at 30 thousand, but they have started Lovenox® injections."

A: ITP is a disorder in which platelets are destroyed by the body and therefore decrease. It is an autoimmune disease, i.e. a disturbance of the immune system: the patient's immune system thinks it needs to get rid of platelets and produces antibodies against them that destroy them. Low platelets typically lead to a bleeding tendency and not a clotting tendency. However, ITP can be associated with the immune disorder antiphospholipid-antibody-syndrome (also see Q/A 21, Q/A 54, Q/A 56). Patients with this disorder may have a clotting tendency in spite of low platelets.

The disorders that cause low platelets and clotting at the same time are:

  1. Antiphospholipid antibody syndrome;
  2. TTP (= thrombotic thrombocytopenic purpura; highly unlikely in the above patient, since it is typically an acute disease and does not present over a three year duration)
  3. HIT (= heparin induced thrombocytopenia; not likely in the above patient, since she was probably not on heparin at the time of diagnosis of ITP or at the time when she presented with the leg clot);
  4. Malignant tumors (unlikely in a young patient);
  5. DIC (= disseminated intravascular coagulation; highly unlikely in a non-hospitalized patient without any serious underlying disease);
  6. Presence of a strong underlying inherited thrombophilia and coincidental occurrence of ITP (= Immune Thrombocytopenia Purpura).
It is often difficult to decide how to treat such a patient, since he/she is (a) at risk for bleeding because of the low platelets and blood thinners (heparin, low-molecular weight heparin, warfarin) make the bleeding risk worse, and (b) the patient needs blood thinners since he/she has an acute clot.

One approach to anticoagulation in patients with low platelets that has recently been used (in the CLOT study; New England Journal of Medicine 2003;349:146-53) has been:

For warfarin anticoagulation For low molecular weight heparin (LMWH) anticoagulation)
If platelets > 100,000: Full-dose: INR 2.0-3.0 Full-dose
If platelets 50 - 100,000 Reduced dose: INR 1.5-2.5 reduced dose
If platelets < 50,000 No warfarin No LMWH


If in the patient with a deep vein thrombosis anticoagulation is stopped or can not be given because of low platelets, one should consider an inferior vena cava filter (transient or permanent IVC filter).

<< Back To Ask The Doctor...

Disclaimer
The information contained on the this web site is provided for your general information only. I am not a doctor and I do not give medical advice or engage in the practice of medicine. I do not recommend any particular treatment/trial for individuals, and in all cases recommend that you consult your physician or local treatment center before pursuing any course of treatment. It is up to you, as a consumer to find out if these trials posted are something you want to participate in. I just post the information.
spacer